Higher Education Institutional Excellence Program of the Ministry of Human Capacities in the framework of the ‘Financial and Public Services’ research project (20764-3/2018/FEKUTSRTAT) at Corvinus University of Budapest:


Healthcare, social burden: current and future costs, need for and evaluation of innovations’ subproject



Due to the aging of society and the increasingly efficient health care in Europe, the care and financing of a growing number of chronic patients is already a major problem in all countries. The share of the health and social sector in GDP is constantly increasing. Therefore, even in the most economically advanced countries, it has become a primary research and strategy planning issue to address the growing need of care. The burden of care on the family is already significant. The aim of our research program is to explore the socio-demographic characteristics, present and expected social costs of the various diseases and conditions, which are critical areas of the health and social care systems and where cost-effective interventions are needed. We intend to contribute to the evaluation of new innovative technologies in this field by using multidisciplinary approaches and societal viewpoints based on country-specific data.

The research aims to provide scientifically sound information for social policy and financing decision making, help with new aspects of planning and sustainable financing of the health and social care system, and promote economically sound resource allocation decisions for chronic diseases and conditions. These are relevant not only for health care, but also for the definition of research, development and training-education directions of other sectors (engineering, pharmaceutical, insurance) of the economy.

Duration: 2018-2021


Leaders of subproject:

Prof. Márta Péntek (1st year)


Prof. Brodszky Valentin (2nd year)




Brodszky V, Tamási B, Hajdu K, Péntek M, Szegedi A, Sárdy M, Bata-Csörgő Z, Kinyó Á, Gulácsi L, Rencz F. Disease burden of patients with pemphigus from a societal perspective. Expert Rev Pharmacoecon Outcomes Res. 2020 Jan 28:1-9. Q2

Baji P, Farkas M, Golicki D, Prevolnik Rupel V, Hoefman R, Brouwer WBF, vanExel J, Zrubka Z, Gulácsi L, Péntek M. Development of Population Tariffs for the CarerQol Instrument for Hungary, Poland and Slovenia: A Discrete Choice Experiment Study to Measure the Burden of Informal Caregiving. Pharmacoeconomics.2020 Mar 23. doi: 10.1007/s40273-020-00899-2. Q1

The European Journal of Health Economics (Impact factor-2018: 2.169; Scimago Q1)

June 2019, Issue 1 Supplement, Pages 1-172

Guest Editor: Márta Péntek

Patient-reported outcomes: opportunities and challenges in Central Europe


Rencz et al. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Qual Life Res. 2019 Jan;28(1):141-152. doi: 10.1007/s11136-018-2003-4. Epub 2018 Sep 17. (Impact factor-2018: 2.488; Scimago Q1)



Some results from the first year of the research programme

Validation of standard questionnaires (measures) and development of population norms:

CarerQol-7D       informal care related quality of life (Hungary, Poland, Slovenia)


SDM-Q-9             The 9-item Shared Decision Making Questionnaire (Hungary)



eHEALS                 The eHEALS Literacy Scale (Hungary)


PREM                    Patient Reported Experience Measures (recommended by the OECD)




Studies with the EQ-5D questionnaire: CEE population norm and available value sets, subjective health expectations and acceptable health states:






Studies in chronic diseases (Crohn disease, pemphigus):



Medical devices, systematic review:


Cost-of-illness studies, systematic review in CEE: